{"id":503,"date":"2019-02-06T09:39:17","date_gmt":"2019-02-06T09:39:17","guid":{"rendered":"http:\/\/www.farmacovigilanciacanarias.org\/noticias\/?p=503"},"modified":"2019-02-06T09:39:17","modified_gmt":"2019-02-06T09:39:17","slug":"nota-informativa-muh-fv-1-2019","status":"publish","type":"post","link":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/2019\/02\/06\/nota-informativa-muh-fv-1-2019\/","title":{"rendered":"Nota Informativa MUH (FV), 1\/2019"},"content":{"rendered":"<table class=\"tablaHome\">\n<tbody>\n<tr>\n<td><a href=\"https:\/\/www.aemps.gob.es\/informa\/notasInformativas\/medicamentosUsoHumano\/seguridad\/2019\/NI_MUH_FV-1-2019-carbimazol-tiamazol.htm\">Carbimazol (Neo-tomizol\u00ae) y tiamazol (Tirodril\u00ae): riesgo de pancreatitis aguda y nuevas recomendaciones sobre anticoncepci\u00f3n durante el tratamiento<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"<p>Carbimazol (Neo-tomizol\u00ae) y tiamazol (Tirodril\u00ae): riesgo de pancreatitis aguda y nuevas recomendaciones sobre anticoncepci\u00f3n durante el tratamiento<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[4],"tags":[],"class_list":["post-503","post","type-post","status-publish","format-standard","hentry","category-seguridad"],"_links":{"self":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/503","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/comments?post=503"}],"version-history":[{"count":1,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/503\/revisions"}],"predecessor-version":[{"id":504,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/posts\/503\/revisions\/504"}],"wp:attachment":[{"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/media?parent=503"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/categories?post=503"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.farmacovigilanciacanarias.org\/noticias\/wp-json\/wp\/v2\/tags?post=503"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}